Patents by Inventor Kevin Janssen

Kevin Janssen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9873908
    Abstract: The detection of the presence of rare somatic mutations from a biological sample is often challenging due to the simultaneous presence of a vast excess of wild-type DNA. The present invention describes methods that would allow the enrichment of mutant DNA by depleting amplifiable wild-type DNA.
    Type: Grant
    Filed: November 19, 2014
    Date of Patent: January 23, 2018
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Amar Gupta, Nancy Schoenbrunner, Kevin Janssen
  • Publication number: 20160053302
    Abstract: The present invention provides for methods and compositions that use visible dyes for the identification of reagents and solutions that are used to perform PCR assays.
    Type: Application
    Filed: April 16, 2015
    Publication date: February 25, 2016
    Inventors: Amar Gupta, Nancy Schoenbrunner, Kevin Janssen, Victoria Brophy
  • Publication number: 20150176060
    Abstract: The present invention provides for methods and compositions that use fluorescent dyes for the identification of reagents and solutions that are used to perform PCR assays.
    Type: Application
    Filed: December 8, 2014
    Publication date: June 25, 2015
    Inventors: Amar Gupta, Nancy Schoenbrunner, Kevin Janssen, Nicolas Newton
  • Publication number: 20150147760
    Abstract: The detection of the presence of rare somatic mutations from a biological sample is often challenging due to the simultaneous presence of a vast excess of wild-type DNA. The present invention describes methods that would allow the enrichment of mutant DNA by depleting amplifiable wild-type DNA.
    Type: Application
    Filed: November 19, 2014
    Publication date: May 28, 2015
    Inventors: Amar Gupta, Nancy Schoenbrunner, Kevin Janssen